{"id":"F2007B01036","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2003)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62498,"registerId":"commonwealth-F2007B01036-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2003)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 1 of 2003\n\nI, ANDREW SEARLE MITCHELL, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration commences on 1 February 2003.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nCarbomer 940\n\nDextran 40 with Glucose\n\nDextran 40 with Sodium Chloride\n\nDextran 70 with Sodium Chloride\n\nFosfestrol Sodium\n\nMethylphenobarbitone\n\nDated this 8th day of January 2003.\n\nANDREW SEARLE MITCHELL\n\nActing Assistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2217},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This is the original 2003 declaration, and its scope remains limited to the specific administrative task of delisting the six named pharmaceutical items from the PBS."},"complexity_factors":["Only 2 operative clauses (commencement date and delisting mechanism)","No defined terms, interpretation section, or complex cross-references","Single administrative action with no conditional logic or exceptions","Schedule contains only a simple list of 6 chemical substances"],"plain_english_summary":"This declaration removed six specific medicines from Australia’s Pharmaceutical Benefits Scheme (PBS) as of 1 February 2003, meaning those drugs stopped receiving government subsidies and patients must pay full price. The list included treatments such as dextran plasma expanders, an eye gel for dry eye, a prostate cancer hormonal therapy, and an anticonvulsant.\n\nA senior Health Department delegate acted on Pharmaceutical Benefits Advisory Committee (PBAC) advice. Delisting reflected obsolescence, market withdrawal, or lack of cost‑effectiveness, affecting any remaining users."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2003/documents"}}